EID Parry (India) Ltd
EID Parry is engaged in Sugar, Nutraceuticals and ethanol production. It also has a significant presence in the Farm Inputs business including Bio pesticides through its subsidiary, Coromandel International Limited. [1]
- Market Cap ₹ 14,188 Cr.
- Current Price ₹ 799
- High / Low ₹ 880 / 453
- Stock P/E 16.1
- Book Value ₹ 398
- Dividend Yield 0.50 %
- ROCE 20.3 %
- ROE 13.5 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 41.2% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11,383 | 12,114 | 13,952 | 15,358 | 14,391 | 15,373 | 16,556 | 17,129 | 18,556 | 23,521 | 35,244 | 29,413 | 29,133 | |
10,356 | 11,212 | 12,938 | 14,517 | 12,965 | 14,068 | 15,105 | 15,242 | 16,467 | 21,146 | 32,088 | 26,825 | 26,742 | |
Operating Profit | 1,027 | 902 | 1,014 | 841 | 1,426 | 1,305 | 1,450 | 1,887 | 2,089 | 2,375 | 3,156 | 2,588 | 2,392 |
OPM % | 9% | 7% | 7% | 5% | 10% | 8% | 9% | 11% | 11% | 10% | 9% | 9% | 8% |
95 | 105 | 105 | 179 | 159 | 150 | 83 | 129 | 17 | 240 | 83 | 304 | 375 | |
Interest | 388 | 465 | 420 | 451 | 417 | 336 | 425 | 430 | 236 | 152 | 298 | 295 | 297 |
Depreciation | 215 | 226 | 244 | 250 | 248 | 251 | 272 | 319 | 332 | 334 | 376 | 421 | 444 |
Profit before tax | 519 | 315 | 455 | 319 | 920 | 868 | 837 | 1,266 | 1,539 | 2,129 | 2,564 | 2,175 | 2,026 |
Tax % | 30% | 31% | 39% | 45% | 23% | 40% | 48% | 30% | 35% | 26% | 29% | 26% | |
363 | 219 | 276 | 175 | 708 | 517 | 438 | 889 | 1,000 | 1,574 | 1,828 | 1,618 | 1,519 | |
EPS in Rs | 11.77 | 4.44 | 6.64 | 1.96 | 29.61 | 14.45 | 8.67 | 26.43 | 25.26 | 51.12 | 53.37 | 50.68 | 49.69 |
Dividend Payout % | 74% | 62% | 89% | 0% | 14% | 21% | 35% | 0% | 0% | 22% | 18% | 8% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 12% |
3 Years: | 17% |
TTM: | -17% |
Compounded Profit Growth | |
---|---|
10 Years: | 28% |
5 Years: | 41% |
3 Years: | 23% |
TTM: | 13% |
Stock Price CAGR | |
---|---|
10 Years: | 14% |
5 Years: | 39% |
3 Years: | 22% |
1 Year: | 54% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 15% |
3 Years: | 16% |
Last Year: | 14% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
Reserves | 2,415 | 2,399 | 2,209 | 2,370 | 2,733 | 2,952 | 3,110 | 3,502 | 4,565 | 5,308 | 6,067 | 7,040 |
5,199 | 4,288 | 4,823 | 5,144 | 3,923 | 4,470 | 5,125 | 4,347 | 1,229 | 1,259 | 1,618 | 1,740 | |
4,802 | 4,954 | 5,849 | 6,600 | 6,691 | 7,088 | 7,649 | 7,069 | 7,444 | 9,358 | 11,076 | 12,688 | |
Total Liabilities | 12,433 | 11,659 | 12,899 | 14,131 | 13,364 | 14,528 | 15,901 | 14,936 | 13,257 | 15,943 | 18,778 | 21,487 |
3,851 | 3,788 | 3,476 | 3,343 | 3,297 | 3,197 | 3,077 | 3,858 | 3,583 | 3,763 | 3,889 | 4,896 | |
CWIP | 489 | 163 | 75 | 77 | 39 | 54 | 203 | 85 | 206 | 160 | 486 | 520 |
Investments | 180 | 358 | 369 | 688 | 569 | 430 | 418 | 413 | 453 | 563 | 609 | 1,275 |
7,914 | 7,350 | 8,979 | 10,022 | 9,459 | 10,847 | 12,203 | 10,579 | 9,014 | 11,456 | 13,794 | 14,796 | |
Total Assets | 12,433 | 11,659 | 12,899 | 14,131 | 13,364 | 14,528 | 15,901 | 14,936 | 13,257 | 15,943 | 18,778 | 21,487 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
838 | 1,591 | 222 | 437 | 1,969 | 259 | -52 | 1,986 | 4,771 | 2,278 | 359 | 1,972 | |
-956 | -260 | -307 | -192 | -148 | 13 | -357 | -282 | -548 | -1,732 | 487 | -1,740 | |
-503 | -1,263 | -142 | -221 | -1,842 | 42 | 34 | -1,769 | -3,598 | -499 | -184 | -497 | |
Net Cash Flow | -621 | 68 | -227 | 23 | -21 | 314 | -375 | -65 | 625 | 47 | 661 | -265 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 65 | 52 | 45 | 49 | 47 | 43 | 46 | 45 | 17 | 9 | 8 | 23 |
Inventory Days | 118 | 123 | 138 | 124 | 127 | 134 | 175 | 131 | 112 | 111 | 81 | 112 |
Days Payable | 122 | 128 | 141 | 145 | 170 | 174 | 172 | 141 | 124 | 114 | 84 | 122 |
Cash Conversion Cycle | 61 | 48 | 42 | 27 | 4 | 3 | 49 | 35 | 6 | 6 | 5 | 12 |
Working Capital Days | 108 | 73 | 84 | 88 | 87 | 90 | 115 | 104 | 60 | 41 | 39 | 42 |
ROCE % | 11% | 9% | 11% | 9% | 16% | 16% | 14% | 18% | 21% | 26% | 27% | 20% |
Documents
Announcements
-
Closure of Trading Window
25 Sep - Trading window closure from October 01, 2024.
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
20 Sep - Allotment of 15084 Equity Shares of Re.1 each arising out of exercise of ESOPs
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
28 Aug - Allotment of 34,486 equity shares under ESOP 2016.
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 23 Aug
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
23 Aug - Transcript of Q1 FY25 earnings conference call.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
Concalls
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT REC
-
Feb 2024TranscriptPPTREC
-
Nov 2023TranscriptPPTREC
-
Aug 2023TranscriptPPT
-
Jun 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
May 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
Aug 2021TranscriptPPT
-
Jun 2021TranscriptPPT
-
Jan 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Jun 2020TranscriptPPT
-
Jan 2020TranscriptPPT
-
Dec 2019TranscriptNotesPPT
-
Oct 2019TranscriptPPT
-
Jul 2019TranscriptPPT
-
May 2019TranscriptPPT
-
Jan 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018TranscriptPPT
-
Jan 2018TranscriptPPT
-
Oct 2017TranscriptPPT
-
May 2017TranscriptPPT
-
Jan 2016TranscriptPPT
Business Segments & Revenue split FY23
Product Segment:Sugar (~70%): Manufacture, sale, and marketing of sugar in various forms. The Sugar is sold both to trade and institutions and also to consumers through retail channels.